These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35614040)

  • 1. FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression.
    Zhu J; Zhao J; Luo C; Zhu Z; Peng X; Zhu X; Lin K; Bu F; Zhang W; Li Q; Wang K; Hu Z; Yu X; Chen L; Yuan R
    Cell Death Dis; 2022 May; 13(5):497. PubMed ID: 35614040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer.
    Liu C; Shi J; Li Q; Li Z; Lou C; Zhao Q; Zhu Y; Zhan F; Lian J; Wang B; Guan X; Fang L; Li Z; Wang Y; Zhou B; Yao Y; Zhang Y
    Clin Sci (Lond); 2019 Mar; 133(5):645-663. PubMed ID: 30782607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells.
    Marchand B; Pitarresi JR; Reichert M; Suzuki K; Laczkó D; Rustgi AK
    Oncogene; 2019 May; 38(22):4325-4339. PubMed ID: 30705403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-Dependent FOXM1 Promotes Epithelial-to-Mesenchymal Transition Via Cellular Metabolism and Targeting Snail in Human Pancreatic Cancer.
    Kyuno T; Kohno T; Konno T; Yamaguchi H; Kyuno D; Imamura M; Kimura Y; Kojima T; Takemasa I
    Pancreas; 2020 Feb; 49(2):273-280. PubMed ID: 32011531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA.
    Du Y; Yang Z; Shi H; Chen Z; Chen R; Zhou F; Peng X; Hong T; Jiang L
    Cell Death Dis; 2024 May; 15(5):340. PubMed ID: 38755129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huaier enhances the tumor-killing effect and reverses gemcitabine-induced stemness by suppressing FoxM1.
    Wang Q; Gong M; Liu R; Mo J; Bai R; An R; Wang X; Han L; Wang Z; Ma Q; Wu Z; Zhou C
    Phytomedicine; 2024 Jul; 129():155656. PubMed ID: 38723529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating forkhead box protein M1.
    Cao J; Li J; Sun L; Qin T; Xiao Y; Chen K; Qian W; Duan W; Lei J; Ma J; Ma Q; Han L
    Mol Oncol; 2019 Feb; 13(2):228-245. PubMed ID: 30367545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
    Roca MS; Moccia T; Iannelli F; Testa C; Vitagliano C; Minopoli M; Camerlingo R; De Riso G; De Cecio R; Bruzzese F; Conte M; Altucci L; Di Gennaro E; Avallone A; Leone A; Budillon A
    J Exp Clin Cancer Res; 2022 Mar; 41(1):83. PubMed ID: 35241126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1.
    Mao L; Le S; Jin X; Liu G; Chen J; Hu J
    Exp Cell Res; 2019 Jan; 374(2):274-281. PubMed ID: 30352219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis.
    Yang RM; Zhan M; Xu SW; Long MM; Yang LH; Chen W; Huang S; Liu Q; Zhou J; Zhu J; Wang J
    Cell Death Dis; 2017 Oct; 8(10):e3129. PubMed ID: 29048402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAT10 promotes the invasion and migration of breast cancer cell through stabilization of ZEB2.
    Zou Y; Ouyang Q; Wei W; Yang S; Zhang Y; Yang W
    Biochem Biophys Res Commun; 2018 Nov; 506(3):563-570. PubMed ID: 30361097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine-induced epithelial-mesenchymal transition-like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal-like phenotype.
    El Amrani M; Corfiotti F; Corvaisier M; Vasseur R; Fulbert M; Skrzypczyk C; Deshorgues AC; Gnemmi V; Tulasne D; Lahdaoui F; Vincent A; Pruvot FR; Van Seuningen I; Huet G; Truant S
    Mol Carcinog; 2019 Nov; 58(11):1985-1997. PubMed ID: 31373074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition.
    Jin H; Zhao Y; Zhang S; Yang J; Zhang X; Ma S
    Mol Med Rep; 2018 May; 17(5):7274-7280. PubMed ID: 29568909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1.
    Chen L; Xu Z; Li Q; Feng Q; Zheng C; Du Y; Yuan R; Peng X
    Cell Death Dis; 2021 Sep; 12(10):887. PubMed ID: 34584067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of MBD1 promotes pancreatic cancer cell epithelial-mesenchymal transition and invasion by epigenetic down-regulation of E-cadherin.
    Xu J; Zhu W; Xu W; Yao W; Zhang B; Xu Y; Ji S; Liu C; Long J; Ni Q; Yu X
    Curr Mol Med; 2013 Mar; 13(3):387-400. PubMed ID: 23331011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasohibin 2 promotes malignant behaviors of pancreatic cancer cells by inducing epithelial-mesenchymal transition via Hedgehog signaling pathway.
    Zhang Y; Xue X; Zhao X; Qin L; Shen Y; Dou H; Sun J; Wang T; Yang DQ
    Cancer Med; 2018 Nov; 7(11):5567-5576. PubMed ID: 30318866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0092367 Inhibits EMT and Gemcitabine Resistance in Pancreatic Cancer via Regulating the miR-1206/ESRP1 Axis.
    Yu S; Wang M; Zhang H; Guo X; Qin R
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer.
    Shi C; Zhang H; Wang M; Tian R; Li X; Feng Y; Peng F; Qin R
    Dig Dis Sci; 2022 Mar; 67(3):915-924. PubMed ID: 33782807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.
    Huang C; Xie D; Cui J; Li Q; Gao Y; Xie K
    Clin Cancer Res; 2014 Mar; 20(6):1477-88. PubMed ID: 24452790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ISG15 Promotes Progression and Gemcitabine Resistance of Pancreatic Cancer Cells Through ATG7.
    Meng Y; Bian L; Zhang M; Zhou P; Zhang S; Ying Y; Yang S; Liu Y; Yao Y; Li D
    Int J Biol Sci; 2024; 20(4):1180-1193. PubMed ID: 38385083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.